In vitroactivity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam againstBurkholderia cepaciacomplex,Burkholderia gladioliand other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients-Reference-Cited by-同舟云学术

In vitroactivity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam againstBurkholderia cepaciacomplex,Burkholderia gladioliand other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients

Published:2018-10-12 Issue:2 Volume:74 Page:525-528
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Massip Clémence¹²,Mathieu Chloé¹³,Gaudru Cécile¹²,Miaut Véronique¹⁴,Floch Pauline¹²,Oswald Eric¹²,Segonds Christine⁴,Guet-Revillet Hélène¹²⁴

Affiliation:

1. Service de Bactériologie-Hygiène, CHU de Toulouse, Toulouse, France

2. IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France

3. Lycée Stéphane Hessel, Toulouse, France

4. Observatoire Burkholderia cepacia, CHU de Toulouse, Toulouse/Vaincre la Mucoviscidose, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/2/525/27524658/dky423.pdf

Reference10 articles.

1. In vitro activity of ceftolozane-tazobactam and other antimicrobial agents against Burkholderia cepacia complex and Burkholderia gladioli;Mazer;Antimicrob Agents Chemother,2017

2. Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles;Livermore;J Antimicrob Chemother,2017

3. In vitro activity of ceftazidime + NXL104 against Pseudomonas aeruginosa and other non-fermenters;Mushtaq;J Antimicrob Chemother,2010

4. In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam;Van Dalem;Antimicrob Agents Chemother,2018

5. Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis;Chiron;J Clin Microbiol,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

2. Prevalence, phenotypic characteristics and genetic diversity of Burkholderia gladioli isolated from edible mushrooms;LWT;2024-02

3. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae;Medicina;2023-10-31

4. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

5. In vitro susceptibility of nonfermenting Gram-negative rods to meropenem–vaborbactam and delafloxacin;Future Microbiology;2023-01